Cargando…

T86. RELEVANCE OF CANNABIS USE AS A PREDICTOR OF CLINICAL OUTCOME IN FIRST-EPISODE SCHIZOPHRENIA SPECTRUM DISORDER PATIENTS OVER 24 MONTHS OF TREATMENT

BACKGROUND: Cannabis use is generally associated with an unfavourable course of illness in first-episode schizophrenia, including non-remission of psychopathology symptoms, higher rates of relapse and re-hospitalization, and poorer functioning. The aim of this study was to explore the influence of c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scheffler, Frederika, Luckhoff, Hilmar, du Plessis, Stefan, Phahladira, Lebogang, Asmal, Laila, Kilian, Sanja, Emsley, Robin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Session III
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234658/ http://dx.doi.org/10.1093/schbul/sbaa029.646

Ejemplares similares

S201. HIPPOCAMPAL SUBFIELD VOLUMES AND CHANGE IN BODY MASS OVER 12 MONTHS OF TREATMENT IN FIRST-EPISODE SCHIZOPHRENIA SPECTRUM DISORDERS
por: Du Plessis, Stéfan, et al.
Publicado: (2020)

Early recovery in the first 24 months of treatment in first-episode schizophrenia-spectrum disorders
por: Phahladira, Lebogang, et al.
Publicado: (2020)

M122. DEPRESSION IN SCHIZOPHRENIA SPECTRUM DISORDERS: LONGITUDINAL COURSE AND THE RELATIONSHIP WITH OTHER CLINICAL PARAMETERS AND QUALITY OF LIFE
por: Phahladira, Lebogang, et al.
Publicado: (2020)

Antipsychotic treatment effects and structural MRI brain changes in schizophrenia
por: Emsley, Robin, et al.
Publicado: (2023)

S100. EFFECTS OF CANNABIS USE ON BODY MASS, FASTING GLUCOSE AND LIPIDS DURING THE FIRST 12 MONTHS OF TREATMENT IN SCHIZOPHRENIA SPECTRUM DISORDERS
por: Scheffler, Frederika, et al.
Publicado: (2018)

F106. STATE AND TRAIT RELATED NATURE OF INSIGHT IMPAIRMENT IN SCHIZOPHRENIA
por: Phahladira, Lebogang, et al.
Publicado: (2018)

S108. ASSOCIATIONS BETWEEN GLOBAL BRAIN MEASURES AND STATE- AND TRAIT- RELATED SYMPTOM EXPRESSION OF SCHIZOPHRENIA
por: Asmal, Laila, et al.
Publicado: (2018)

Instruments Measuring Blunted Affect in Schizophrenia: A Systematic Review
por: Kilian, Sanja, et al.
Publicado: (2015)

Associations of premorbid adjustment with type and timing of childhood trauma in first-episode schizophrenia spectrum disorders
por: Smit, Anna M., et al.
Publicado: (2021)

Factors associated with dropout at 2 years post-initiation of treatment in the first episode of schizophrenia
por: Benelmokhtar, Jebril M., et al.
Publicado: (2021)

T2. ADVERSE CHILDHOOD EXPERIENCES IN PEOPLE WITH SCHIZOPHRENIA
por: Klaunig, Mallory, et al.
Publicado: (2020)

Two Neuroanatomical Signatures in Schizophrenia: Expression Strengths Over the First 2 Years of Treatment and Their Relationships to Neurodevelopmental Compromise and Antipsychotic Treatment
por: du Plessis, Stefan, et al.
Publicado: (2023)

Childhood trauma exposure and reward processing in healthy adults: A functional neuroimaging study
por: Hendrikse, Chanellé Juanita, et al.
Publicado: (2022)

T148. FIRST EPISODE PSYCHOSIS, TRAUMA AND SUBSTANCE USE IN A HIGH HIV PREVALENCE SETTING IN SUB-SAHARAN AFRICA
por: Ntlantsana, Vuyokazi, et al.
Publicado: (2020)

M102. MEASURING PHYSIOLOGICAL RESPONSES ASSOCIATED WITH SOCIAL STRESS IN A VIRTUAL ENVIRONMENT AND ITS RELATIONSHIP WITH CHILDHOOD TRAUMA IN EARLY SCHIZOPHRENIA - A PILOT STUDY
por: Du Plessis, Stéfan, et al.
Publicado: (2020)

T84. PREMORBID ADJUSTMENT AND IQ IN PATIENTS WITH FIRST-EPISODE PSYCHOSIS: A MULTISITE CASE-CONTROL STUDY OF THEIR RELATIONSHIP WITH CANNABIS USE
Publicado: (2020)

Cognitive-perceptual deficits and symptom correlates in first-episode schizophrenia
por: Olivier, Riaan M., et al.
Publicado: (2017)

T24. CHANGES IN TELOMERE LENGTH IN YOUNG PEOPLE WITH FIRST EPISODE PSYCHOSIS: A 12-MONTHS FOLLOW-UP STUDY
por: Ayora, Mirian, et al.
Publicado: (2020)

T117. PROMINENT AND PERSISTENT AUTISTIC TRAITS ARE ASSOCIATED WITH EARLY NON-REMISSION IN FIRST-EPISODE SCHIZOPHRENIA
por: Pina-Camacho, Laura, et al.
Publicado: (2020)

T92. POSSIBLE COMBINATIONS OF DSM-IV AND DSM-5 CRITERIA IN SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER VERSUS MAJOR DEPRESSIVE AND MANIC EPISODES
por: Kontis, Dimitrios, et al.
Publicado: (2020)

T121. BLUNTED AFFECT EARLY PROGRESSION IN DRUG-NAïVE FIRST EPISODE SCHIZOPHRENIA PATIENTS: 10-WEEK FOLLOW UP
por: Kagan, Simão, et al.
Publicado: (2020)

T87. CHANGING RATES OF PAST-YEAR CANNABIS USE BY PEOPLE WITH A PSYCHOTIC DISORDER
por: Waterreus, Anna, et al.
Publicado: (2020)

Extrapyramidal side effects in first-episode schizophrenia treated with flupenthixol decanoate
por: Joubert, Francois-Pierre, et al.
Publicado: (2021)

T25. THE RELATIONSHIP BETWEEN AGE AT FIRST-EPISODE AND LONGITUDINAL CORTICAL CHANGES IN FIRST-EPISODE PSYCHOSIS: A TWO-YEAR LONGITUDINAL STUDY IN AN ADOLESCENT AND ADULT-ONSET COHORT
por: Santonja, Javier, et al.
Publicado: (2020)

T238. RATES AND PREDICTORS OF RELAPSE IN AN AUSTRALIAN FIRST EPISODE PSYCHOSIS COHORT
por: Brown, Ellie, et al.
Publicado: (2020)

T66. IS COGNITIVE PERFORMANCE ASSOCIATED WITH ANXIETY AND DEPRESSION IN FIRST-EPISODE PSYCHOSIS?
Publicado: (2020)

Factors Moderating the Relationship Between Childhood Trauma and Premorbid Adjustment in First-Episode Schizophrenia
por: Kilian, S., et al.
Publicado: (2017)

Erratum: Extrapyramidal side effects in first-episode schizophrenia treated with flupenthixol decanoate
por: Joubert, Francois-Pierre, et al.
Publicado: (2021)

T72. COGNITIVE CLUSTERS IN FIRST-EPISODE PSYCHOSIS AND THEIR RELATIONSHIP TO SYMPTOMATOLOGY AND DEVELOPMENTAL SCHOLASTIC PERFORMANCE
por: Tan, Eric, et al.
Publicado: (2020)

T120. INFLUENCE OF MATERNAL AND PATERNAL HISTORY IN SYMPTOMS, COGNITION AND METACOGNITION IN PEOPLE WITH FIRST-EPISODE PSYCHOSIS
por: López-Carrilero, Raquel, et al.
Publicado: (2020)

T40. GLYCERYL TRINITRATE IN FIRST EPISODE PSYCHOSIS UNMEDICATED WITH ANTIPSYCHOTICS: A RANDOMISED CONTROLLED FEASIBILITY STUDY
por: Merritt, Kate, et al.
Publicado: (2020)

T14. HYPOTHALAMIC-PITUITARY-GONADAL AXIS HORMONES IN ANTIPSYCHOTIC NAïVE FIRST-EPISODE OF PSYCHOSIS AND HEALTHY CONTROLS
por: Teresa Pons-Cabrera, Maria, et al.
Publicado: (2020)

T105. VERBAL MEMORY MEASUREMENT TOWARDS DIGITAL PERSPECTIVES IN FIRST-EPISODE PSYCHOSIS: A SYSTEMATIC REVIEW STUDY
por: Kilciksiz, Can, et al.
Publicado: (2020)

T155. PROGRESSION OF NEUROANATOMICAL ABNORMALITIES AFTER FIRST-EPISODE OF PSYCHOSIS: A 3-YEAR LONGITUDINAL STRUCTURAL MRI STUDY
por: Akudjedu, Theophilus, et al.
Publicado: (2020)

T158. NO ALTERATION OF PITUTARY VOLUME IN PATIENTS WITH FIRST-EPISODE SCHIZPHRENIA BUT A TREND OF ENLARGEMENT IN NON-PSYCHOTIC FIRST-DEGREE RELATIVES
por: Chu, Min-yi, et al.
Publicado: (2020)

T192. BINSWANGER’S THREE FORMS OF FAILED EXISTENCE AND ITS RELEVANCE FOR CONTEMPORARY PSYCHIATRY
por: Nilsson, Lars
Publicado: (2020)

T154. WHITE MATTER INTEGRITY, DURATION OF UNTREATED PSYCHOSIS, AND ANTIPSYCHOTIC TREATMENT RESPONSE IN MEDICATION-NAïVE FIRST EPISODE PSYCHOSIS PATIENTS
por: Kraguljac, Nina, et al.
Publicado: (2020)

T119. NO DIFFERENCE BETWEEN VOLITIVE AND EXPRESSIVE NEGATIVE SYMPTOMS FOR EARLY TREATMENT RESPONSE IN FIRST EPISODE OF PSYCHOSIS ANTIPSYCHOTIC NAïVE PATIENTS
por: Haguiara, Bernardo, et al.
Publicado: (2020)

T203. RELEVANT CLOZAPINE BLOOD LEVELS USING A POINT OF CARE TEST (POCT)
por: Kelly, Deanna, et al.
Publicado: (2020)

T183. LOW LEVELS OF VITAMIN D ARE ASSOCIATED WITH REDUCED CORTICAL THICKNESS AND SURFACE AREA IN FRONTAL, TEMPORAL AND OCCIPITAL REGIONS IN FIRST-EPISODE PSYCHOSIS PATIENTS
por: Ciufolini, Simone, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8jq7v4odm51gha8cvhr8bi3ree